$110 Million is the total value of Wilson & Boucher Capital Management, LLC's 112 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARKG | Exit | ARK Genomic Revolution | $0 | – | -3,660 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-04-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Vanguard Total Stock Mkt ETF | 8 | Q3 2023 | 6.6% |
| Apple | 8 | Q3 2023 | 6.4% |
| Schwab US Broad Market ETF | 8 | Q3 2023 | 4.1% |
| Vanguard Index Small Cap ETF | 8 | Q3 2023 | 3.8% |
| Novo Nordisk A/S ADR Fmly Novo | 8 | Q3 2023 | 4.9% |
| Vanguard Mid Cap Index ETF | 8 | Q3 2023 | 2.9% |
| Microsoft | 8 | Q3 2023 | 2.6% |
| Pepsico | 8 | Q3 2023 | 2.6% |
| Stryker | 8 | Q3 2023 | 2.4% |
| SPDR Utilities Select ETF | 8 | Q3 2023 | 2.3% |
View Wilson & Boucher Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-01 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR/A | 2023-01-19 |
| 13F-HR | 2023-01-11 |
| 13F-HR | 2022-10-24 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-04-12 |
View Wilson & Boucher Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.